The US Centers for Medicare and Medicaid Services is taking at least one message away from the first round of patient feedback meetings it hosted as part of the Medicare drug price negotiation process: the format it used in 2023 did not work particularly well.
Patient Input In US Medicare Price Negotiation: Will CMS Close The Door?
The US Medicare agency is planning to modify its patient input process for feedback on products selected for price cuts in the program’s second year. The list of options includes holding the meetings in less public settings.
